1. Home
  2. CCTG vs ENSC Comparison

CCTG vs ENSC Comparison

Compare CCTG & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CCSC Technology International Holdings Limited

CCTG

CCSC Technology International Holdings Limited

N/A

Current Price

$0.29

Market Cap

8.9M

Sector

N/A

ML Signal

N/A

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

N/A

Current Price

$0.43

Market Cap

7.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCTG
ENSC
Founded
1993
2003
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
7.6M
IPO Year
2022
2017

Fundamental Metrics

Financial Performance
Metric
CCTG
ENSC
Price
$0.29
$0.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
★ $5.13
AVG Volume (30 Days)
373.3K
★ 526.9K
Earning Date
07-17-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 65.24
EPS
★ N/A
N/A
Revenue
N/A
★ $5,066,650.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.08
$0.23
52 Week High
$5.64
$2.21

Technical Indicators

Market Signals
Indicator
CCTG
ENSC
Relative Strength Index (RSI) 26.22 40.22
Support Level N/A $0.39
Resistance Level $0.54 $0.44
Average True Range (ATR) 0.05 0.05
MACD -0.00 -0.01
Stochastic Oscillator 44.55 0.00

Price Performance

Historical Comparison
CCTG
ENSC

About CCTG CCSC Technology International Holdings Limited

CCSC Technology International Holdings Ltd, through its direct wholly-owned subsidiaries, is principally engaged in the manufacturing and sale of interconnect products, including connectors, cables and wire harnesses. The company produces both original equipment manufacturer (OEM) and original design manufacturer (ODM) interconnect products for manufacturing companies that produce end products, as well as for electronic manufacturing services (EMS) companies. The majority of the company's revenue is derived from the sale of Cable and wire harnesses, and Connectors. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas, Asia, and Others.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: